Company: PFSA
Filing Date: 2025-02-18
Form Type: PRE 14A
Source: 0001213900-25-014919
Chunk: 19

Company: Profusa, Inc.
Filing Date: 2025-02-18
Form: PRE 14A
Chunk 19
---
 purchase shares of common stock in the open market or in privately negotiated transactions in connection with
the stockholder vote on the Extension Amendment.

Recommendation of the Board

After careful consideration of all relevant factors, our Board has
determined that the Extension Amendment is in the best interests of the Company and its stockholders. Our Board has approved and declared
advisable adoption of the Extension Proposal.

Our Board unanimously recommends that our stockholders vote “FOR” the approval of the Extension Proposal.

Interests of our Sponsor, Directors and Officers and the Representatives

When you consider the recommendation of our Board, you should keep
in mind that our Sponsor, executive officers and members of our Board have interests that may be different from, or in addition to, your
interests as a stockholder. These interests include, among other things:

| ● | our Sponsor and its affiliates own 4,743,750 Founder Shares and 450,000 Representative Shares; none of these securities (which represent     
 an aggregate investment of $7,372,500) are subject to redemption, and all will expire worthless if a business combination is not consummated 
 by March 22, 2025, unless the Extension Amendment is implemented;                                                                            |

| ● | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required  
 time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.10 per     
 public share, or such lesser per public share amount as is in the Trust Account on the liquidation date, by the claims of prospective     
 target businesses with which we have entered into an acquisition agreement or claims of any third party for services rendered or products 
 sold to us, but only if such a third party or target business has not executed a waiver of any and all rights to seek access to the Trust 
 Account; and                                                                                                                              |

| ● | none of our officers or directors has received any cash compensation for services rendered to the Company, and all of the current          
 members of our Board are expected to continue to serve as directors at least through the date of the special meeting to vote on a proposed 
 business combination and may even continue to serve following any potential business combination and receive compensation thereafter.      |

<div align='center'>18</div>

Our securities were suspended from trading and delisted from Nasdaq on December 27, 2024, following receipt of a delisting determination letter from Nasdaq on